Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.05 - $2.85 $2,038 - $5,531
-1,941 Reduced 13.41%
12,535 $15,000
Q2 2022

Aug 15, 2022

SELL
$0.63 - $2.96 $11,501 - $54,037
-18,256 Reduced 55.77%
14,476 $26,000
Q1 2022

May 16, 2022

SELL
$1.43 - $3.14 $35,561 - $78,085
-24,868 Reduced 43.17%
32,732 $66,000
Q4 2021

Feb 14, 2022

BUY
$2.7 - $4.76 $155,520 - $274,176
57,600 New
57,600 $156,000
Q3 2020

Nov 16, 2020

SELL
$4.82 - $7.72 $240,489 - $385,181
-49,894 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$5.69 - $9.69 $283,896 - $483,472
49,894 New
49,894 $336,000
Q4 2019

Feb 18, 2020

SELL
$3.0 - $16.43 $580,164 - $3.18 Million
-193,388 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$3.93 - $15.35 $93,785 - $366,312
23,864 Added 14.08%
193,388 $760,000
Q2 2019

Aug 14, 2019

BUY
$12.81 - $25.67 $25,620 - $51,340
2,000 Added 1.19%
169,524 $2.52 Million
Q1 2019

May 15, 2019

SELL
$17.66 - $30.28 $2.82 Million - $4.84 Million
-159,746 Reduced 48.81%
167,524 $4.16 Million
Q4 2018

Feb 14, 2019

BUY
$11.63 - $32.67 $2.78 Million - $7.8 Million
238,697 Added 269.49%
327,270 $5.88 Million
Q3 2018

Nov 14, 2018

SELL
$29.37 - $49.48 $2.04 Million - $3.43 Million
-69,395 Reduced 43.93%
88,573 $2.6 Million
Q2 2018

Aug 14, 2018

BUY
$42.06 - $62.4 $6.64 Million - $9.86 Million
157,968 New
157,968 $7.18 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.